Tech Company Financing Transactions
Celtaxsys Funding Round
Celtaxsys, based in Atlanta, scored $4.2 million in investment from private investors.
Transaction Overview
Company Name
Announced On
10/29/2010
Transaction Type
Venture Equity
Amount
$4,231,386
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
311 Ferst Dr. Northwest 530
Atlanta, GA 30318
USA
Atlanta, GA 30318
USA
Phone
Website
Email Address
Not Recorded
Overview
Celtaxsys is a clinical-stage pharmaceutical development company focused on advancing novel foundational therapies to treat inflammation in rare, orphan designated diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Greg Duncan
Chief Scientific Officer
Eric Springman
VP - Finance
Angela Walsh
VP - Operations
Ralph Grosswald
Browse more venture capital transactions:
Prev: 10/29/2010: SnapLogic venture capital transaction
Next: 10/29/2010: Conatus Pharmaceuticals venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs